The prognostic significance of minimal residual disease in adult Egyptian patients with precursor acute lymphoblastic leukemia
Conclusion MRD by FCM is a strong independent predictor of outcome in terms of DFS and OS and is a powerful informative parameter in guiding individual treatment in ALL patients.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Egypt Health | Leukemia | Study